Overarching theme | Proposal for primary care implementation |
---|---|
Holistic Assessment: Pain | % patients with a working diagnosis of OA with evidence of pain assessment within the previous 12 months |
Holistic Assessment: Function | % patients with a working diagnosis of OA with evidence of function assessment within the previous 12 months |
Education | % patients with a working diagnosis of OA with evidence of education or advice since diagnosis |
Exercise 1 | % patients with a working diagnosis of OA in the hip or knee with evidence of exercise advice or physiotherapy referral since diagnosis |
Exercise 2 | % patients with a working diagnosis of OA with evidence of an activity review within the previous 12 months |
Weight loss 1 | % patients with a BMI ≥30 kg/m2 who have a record of weight loss advice within the previous 12 months |
Weight loss 2 | % patients with a working diagnosis of OA with a BMI ≥25 kg/m2 who have a record of weight loss advice within the previous 12 months |
Aids and devices 1 | % patients with a working diagnosis of OA with evidence of functional impairment who are recorded as receiving a referral or assessment for ambulatory assistive devices within the previous 12 months |
Aids and devices 2 | % patients with a working diagnosis of OA with evidence of functional impairment who are recorded as receiving a referral or assessment for assistive devices within the previous 12 months |
Paracetamol 1 | % patients with a working diagnosis of OA with evidence of paracetamol as the first oral analgesic prescribed or advised since diagnosis |
Paracetamol 2 | % patients with a working diagnosis of OA taking oral analgesics or NSAIDs with evidence that a suitable maximal dose of paracetamol was tried beforehand |
Oral NSAIDs 1 | % patients with a working diagnosis of OA with evidence of a standard NSAID or COX-2 inhibitor as the first oral NSAID prescribed or advised since diagnosis |
Oral NSAIDs 2 | % patients with a working diagnosis of OA taking an oral NSAID with a documented risk assessment prior to first prescription |
Gastroprotection | % patients with a working diagnosis of OA taking an oral NSAID who are also prescribed a PPI or alternative gastroprotective agent |
Specialist assessment | % patients with a record of achievement of all other applicable indicators prior to specialist referral* |
*That is, the other 14 indicators above, depending on applicability of weight and therapy indicators to individual patients.
BMI, body mass index; COX, cyclooxygenase; NSAIDs, non-steroidal anti-inflammatories; OA, Osteoarthritis; PPI, proton-pump inhibitor.